Impact Factor
3.06
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
1.91
773 total citations
h5-index
31
h5 depth signal
Cited share
44.9%
188 of 419
Total citations
773
Citation footprint
Metric signal
1.95
External metric anchor
Self-citation
3.4%
26 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
1,444
Mexico
71
Canada
69
United Kingdom
56
Australia
53
Citing Fields of Research
Antibiotic & Antibacterial Agents
682
Virology
426
HIV
137
Hematology
136
Viral Identification & Phylogenetics
114
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,453
Articles tracked across the journal lifetime
Indexed publication set
419
188 cited publications
Last 12 months
333
27.8 publications/month
Open access share
9.3%
31 OA publications in the last year
Leading citing country
United States
1,444 citing publications
Leading citing field
Antibiotic & Antibacterial Agents
682 citing publications
Latest tracked publication
16 October 2026
10 recent records available
Coverage & Indexing History
v4n1, Mar. 2015-
v4n1, Mar. 2015- ; selected citations only before this date
Research Focus & Classification
Indexed Subjects
Antibiotic & Antibacterial Agents
Issuing & Sponsoring Bodies
Contributor
Pediatric Infectious Diseases Society
Broad Categories
Communicable Diseases
Pediatrics
Antibiotic & Antibacterial Agents
Virology
Viral Identification & Phylogenetics
HIV
MeSH Descriptors
Bacterial Infections
Child
Infections
Mycoses
Virus Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/jpids/piag112
Open DOI
Incidence and Risk Factors for Invasive Mold Infections in Children During First-Line Chemotherapy for Primary Acute Leukemia: A National Retrospective Cohort Study
Background: Invasive mold infections (IMI) are life-threatening complications during treatment for pediatric acute leukemia. Population-based data on IMI incidence, timing, and outcomes during first-line therapy remain limited. We aimed ...
02
DOI 10.1093/jpids/piag111
Open DOI
Measles Vaccine Uptake During the 2025 Texas Measles Outbreak in a San Antonio Military Medical Center
Objective: To evaluate changes in measles-containing vaccine (MCV) uptake, inclusive of MMR and MMRV, by age group and over time during the 2025 Texas measles outbreak. Methods: We conducted a retrospective, single-center, observational ...
03
DOI 10.1093/jpids/piag109
Open DOI
Real-World Use of Ceftazidime–Avibactam for Carbapenem-Resistant Enterobacterales Infections in Children: A 7-Year Cohort From a Latin American Referral Center
Background: Pediatric data on ceftazidime-avibactam (CAZ-AVI) for carbapenem-resistant Enterobacterales (CRE) infections remain limited, particularly in Latin America, where KPC-producing organisms are endemic. We describe the clinical c...
04
DOI 10.1093/jpids/piag110
Open DOI
Twenty-Four Month Clinical and Laboratory Follow-Up of Children Infected During a Shiga toxin-Producing Escherichia coli Outbreak
Background: Shiga toxin-producing Escherichia coli (STEC) infections can cause significant long-term renal sequelae. Intermediate-term outcomes for patients who do not develop hemolytic uremic syndrome (HUS) remain unclear. We evaluated ...
05
DOI 10.1093/jpids/piag083
Open DOI
The History of Pediatric Infectious Diseases Society (PIDS)
06
DOI 10.1093/jpids/piag077
Open DOI
THE HISTORICAL HIGHLIGHTS OF Asian Society for Pediatric Infectious Diseases (ASPID) (1994-2026)
07
DOI 10.1093/jpids/piag080
Open DOI
HISTORY OF THE MEXICAN ASSOCIATION OF PEDIATRIC INFECTIOUS DISEASES (AMIP)
08
DOI 10.1093/jpids/piag076
Open DOI
Introduction to the Histories of Pediatric ID Societies
09
10
DOI 10.1093/jpids/piag079
Open DOI
History of the African Society for Paediatric Infectious Diseases (AfSPID)
Bibliographical & Catalog Notes
Also issued online.